These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19378857)

  • 1. [Blood platelets metabolic and activation processes and options for their inhibition].
    Pecka M; Malý J
    Vnitr Lek; 2009 Mar; 55(3):263-6. PubMed ID: 19378857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
    Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
    Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets].
    Yu W; Xu L
    Yao Xue Xue Bao; 1998; 33(1):62-3. PubMed ID: 11938938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of milrinone on platelet activation as determined by TEG platelet mapping.
    Wesley MC; McGowan FX; Castro RA; Dissanayake S; Zurakowski D; Dinardo JA
    Anesth Analg; 2009 May; 108(5):1425-9. PubMed ID: 19372315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacological regulation of thrombocyte activity].
    Dukhanin AS; Gubaeva FR
    Eksp Klin Farmakol; 1998; 61(4):66-71. PubMed ID: 9783114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal vein occlusion disease and platelet activation: will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?
    Fateh-Moghadam S; Gawaz M
    Thromb Haemost; 2007 Feb; 97(2):169-70. PubMed ID: 17264941
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
    Smout J; Cleanthis M; Stansby G
    Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
    Lippi G; Franchini M; Targher G
    Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
    [No Abstract]   [Full Text] [Related]  

  • 10. A shortcut to peptides to modulate platelets.
    Apic G; Russell RB
    Nat Chem Biol; 2007 Feb; 3(2):83-4. PubMed ID: 17235341
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies.
    Ahrens I; Peter K
    Thromb Haemost; 2008 May; 99(5):803-4. PubMed ID: 18449408
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting shear stress-induced platelet activation: is lesion-specific antiplatelet therapy a realistic clinical goal?
    Kroll MH; Feng S
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):941-51. PubMed ID: 16181038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function in intravascular device implant-induced intimal injury.
    Tesfamariam B
    Cardiovasc Revasc Med; 2008; 9(2):78-87. PubMed ID: 18486081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for antiplatelet targets and agents.
    Xiang YZ; Kang LY; Gao XM; Shang HC; Zhang JH; Zhang BL
    Thromb Res; 2008; 123(1):35-49. PubMed ID: 18571699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside.
    Lippi G; Favaloro EJ; Salvagno GL; Franchini M
    Clin Chim Acta; 2009 Jul; 405(1-2):8-16. PubMed ID: 19351529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic targets at the platelet vascular interface.
    Brass LF; Zhu L; Stalker TJ
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s43-50. PubMed ID: 18174448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on "Expression of amyloid beta peptide in human platelets: pivotal role of the phospholipase C gamma2-protein kinase C pathway in platelet activation" by Shen et al.
    Casoli T; Di Stefano G
    Pharmacol Res; 2008 Jul; 58(1):85. PubMed ID: 18662783
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparations affecting arachidonic acid metabolism in the thrombocytes in the treatment of ischemic heart disease].
    Liusov VA; Uteshev DV; Volov NA; Teplova NN; Otarova SM
    Eksp Klin Farmakol; 1995; 58(4):76-9. PubMed ID: 7580760
    [No Abstract]   [Full Text] [Related]  

  • 20. Invited commentary.
    Hiramatsu Y
    Ann Thorac Surg; 2005 Jul; 80(1):257-8. PubMed ID: 15975377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.